The Investment Column: Scotia scrabbles for a success
Thursday 25 September 1997
Though the deal breathed new life into Scotia's shares, which picked up a further 18.5p to 436p on yesterday's interim results, the price has still not recovered from the news in March that Tarabetic, Scotia's lead drug for diabetic nerve damage, which has been under development since 1991, failed to win UK approval. That announcement lopped almost a quarter off the group's value in a day.
Scotia must prove that it can turn evening primrose oil into real prescription drugs, not just food supplements and treatments for ailments such as eczema. Most other drug groups have already dismissed oil-based technology in favour of proteins. The question is whether Scotia knows something that the others do not.
The company believes that Tarabetic will eventually get approval. It is equally confident about its treatment for cancer, codenamed EF13, and EF5 for arthritis. However recent news that EF5 does not work in one group of trial patients is hardly reassuring.
The technology needs to work if Scotia is to justify the money it is ploughing into research and marketing. Increases in these costs in the half-year to June meant operating losses deepened by almost three-quarters to pounds 13m. Even its pounds 60m of available cash is only enough to last two years. That Scotia is already scrabbling for new ways to raise funds - like a Nasdaq listing or spinning off its fast-growing nutrients business - sits uncomfortably with the view of David Horrobin, chief executive, that Scotia will be cash-positive by 2000. Until Scotia scores a drug success, the shares are high enough.
- 1 Indonesia executions: Death row British grandmother Lindsay Sandiford will refuse to wear a blindfold when she faces firing squad
- 2 The man who filmed the Freddie Gray video has been arrested at gunpoint
- 3 How the language you speak changes your view of the world
- 4 The top 50 cities for young people to live in
- 5 Uploading pictures to find out how old you are gives Microsoft the right to post them wherever they want
General Election 2015: Fishing is on Nigel Farage's mind as he casts a line to the disaffected of Grimsby
Oxygen-starved 'dead zones' with no marine life up to 100-miles long discovered in the Atlantic Ocean
The man who filmed the Freddie Gray video has been arrested at gunpoint
Indonesia executions: Death row British grandmother Lindsay Sandiford will refuse to wear a blindfold when she faces firing squad
Russian warships accused of 'chasing away' Swedish vessel to prevent Baltic States from achieving energy independence
Over 50,000 families shipped out of London boroughs in the past three years due to welfare cuts and soaring rents
EU asylum policy is 'a direct threat to our civilisation', says Nigel Farage
The Rothschild Libel: Why has it taken 200 years for an anti-Semitic slur that emerged from the Battle of Waterloo to be dismissed?
General Election 2015: SNP and its activists 'openly racist' towards the English, Farage says
General Election 2015: UK will be 'run for the wealthy and powerful' if Tories retain power, Labour warns
Schools forced to act as 'miniature welfare states' with teachers buying underwear and even haircuts for poor pupils
iJobs Money & Business
£16000 - £18500 per annum: Recruitment Genius: This is an excellent opportunit...
£24000 - £28000 per annum: Recruitment Genius: A Senior SEO Executive is requi...
£16000 - £18000 per annum: Recruitment Genius: An Online customer Service Admi...
£18000 - £22000 per annum: Recruitment Genius: This global, industry leading, ...